Glenmark Pharmaceuticals LimitedNSE: GLENMARK

Press Release Dec 01 2020

· Issued by Glenmark Pharmaceuticals Limited

Filed with NSE ·

Glenmark Pharmaceuticals Limited has informed the Exchange regarding a press release dated December 01, 2020, titled "Glenmark Pharmaceuticals receives ANDA tentative approval for Axitinib Tablets, 1 mg and 5 mg".

View Attachment

6ix hasn’t read this filing yet.

Glenmark Pharmaceuticals Limited on 6ix

Earlier from Glenmark Pharmaceuticals

Later from Glenmark Pharmaceuticals

All Glenmark Pharmaceuticals news releases